Home > News > NanoSight receives investment funds
February 2nd, 2004
NanoSight receives investment funds
NanoSight Ltd, a UK based developer of nanometer scale imaging technologies today announced that it has received an Invention and Innovation investment of £100,000 from NESTA. This follows on from the recently announced signing of a Licence Agreement between NanoSight and Smiths Detection – Watford Ltd. This Licence Agreement allows Smiths Detection a world-wide exclusive licence for the NanoSight patented nanoscale detection and imaging technology for the detection of biological hazards.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014